Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lemaitre Vascular (LMAT) Payables (2016 - 2025)

Historic Payables for Lemaitre Vascular (LMAT) over the last 17 years, with Q3 2025 value amounting to $3.5 million.

  • Lemaitre Vascular's Payables rose 10987.28% to $3.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.5 million, marking a year-over-year increase of 10987.28%. This contributed to the annual value of $1.8 million for FY2024, which is 5283.88% down from last year.
  • Lemaitre Vascular's Payables amounted to $3.5 million in Q3 2025, which was up 10987.28% from $4.9 million recorded in Q2 2025.
  • Lemaitre Vascular's Payables' 5-year high stood at $4.9 million during Q2 2025, with a 5-year trough of $1.7 million in Q3 2024.
  • Over the past 5 years, Lemaitre Vascular's median Payables value was $2.8 million (recorded in 2022), while the average stood at $2.9 million.
  • Its Payables has fluctuated over the past 5 years, first plummeted by 6222.83% in 2024, then skyrocketed by 14631.58% in 2025.
  • Lemaitre Vascular's Payables (Quarter) stood at $2.3 million in 2021, then rose by 24.06% to $2.9 million in 2022, then rose by 28.63% to $3.7 million in 2023, then crashed by 52.84% to $1.8 million in 2024, then soared by 96.76% to $3.5 million in 2025.
  • Its last three reported values are $3.5 million in Q3 2025, $4.9 million for Q2 2025, and $2.2 million during Q1 2025.